ReP USP - Resultado da busca

Artigo de periodico
P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway (2021)
Zaparte, Aline ; Cappellari, Angélica Regina; Brandão, Caroline A; Souza, Julia Bazana de; Borges, Thiago J; Kist, Luiza Wilges; Bogo, Maurício R; Zerbini, Luiz F; Pinto, Luis Felipe Ribeiro; Glaser, Talita ; Gonçalves, Maria Carolina Bittencourt; Naaldijk, Yahaira; Ulrich, Henning ; Morrone, Fernanda B
Source: European Journal of Pharmacology. Unidade: IQ
Subjects: NEOPLASIAS ESOFÁGICAS, NUCLEOTÍDEOS, PROLIFERAÇÃO CELULAR, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAPARTE, Aline et al. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. European Journal of Pharmacology, v. 891, p. 1-12 art. 173687, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173687. Acesso em: 08 nov. 2024.
APA
Zaparte, A., Cappellari, A. R., Brandão, C. A., Souza, J. B. de, Borges, T. J., Kist, L. W., et al. (2021). P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. European Journal of Pharmacology, 891, 1-12 art. 173687. doi:10.1016/j.ejphar.2020.173687
NLM
Zaparte A, Cappellari AR, Brandão CA, Souza JB de, Borges TJ, Kist LW, Bogo MR, Zerbini LF, Pinto LFR, Glaser T, Gonçalves MCB, Naaldijk Y, Ulrich H, Morrone FB. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway [Internet]. European Journal of Pharmacology. 2021 ; 891 1-12 art. 173687.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173687
Vancouver
Zaparte A, Cappellari AR, Brandão CA, Souza JB de, Borges TJ, Kist LW, Bogo MR, Zerbini LF, Pinto LFR, Glaser T, Gonçalves MCB, Naaldijk Y, Ulrich H, Morrone FB. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway [Internet]. European Journal of Pharmacology. 2021 ; 891 1-12 art. 173687.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173687
Artigo de periodico
Purinergic modulation of pathways associated to suicidal behavior (2020)
Gonçalves, Maria Carolina Bittencourt; Velloso, Juliana Correa; Naaldijk, Yahaira; Cheffer, Arquimedes; Ulrich, Henning
Source: Molecular Psychiatry. Unidade: IQ
Subjects: SUICÍDIO, NEUROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Maria Carolina Bittencourt et al. Purinergic modulation of pathways associated to suicidal behavior. Molecular Psychiatry, v. 25, p. 514-516, 2020Tradução . . Acesso em: 08 nov. 2024.
APA
Gonçalves, M. C. B., Velloso, J. C., Naaldijk, Y., Cheffer, A., & Ulrich, H. (2020). Purinergic modulation of pathways associated to suicidal behavior. Molecular Psychiatry, 25, 514-516.
NLM
Gonçalves MCB, Velloso JC, Naaldijk Y, Cheffer A, Ulrich H. Purinergic modulation of pathways associated to suicidal behavior. Molecular Psychiatry. 2020 ; 25 514-516.[citado 2024 nov. 08 ]
Vancouver
Gonçalves MCB, Velloso JC, Naaldijk Y, Cheffer A, Ulrich H. Purinergic modulation of pathways associated to suicidal behavior. Molecular Psychiatry. 2020 ; 25 514-516.[citado 2024 nov. 08 ]
Trabalho de evento-resumo periodico
Purinergic signaling in bipolar disorder (2019)
Gonçalves, Maria Carolina Bittencourt; Naaldijk, Yahaira; Ulrich, Henning
Source: Purinergic Signalling. Conference titles: International Basic and Translational Science on Purinergic Signaling and its Components for a Health and Better World/PURINES. Unidade: IQ
Subjects: TRANSTORNO BIPOLAR, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Maria Carolina Bittencourt e NAALDIJK, Yahaira e ULRICH, Henning. Purinergic signaling in bipolar disorder. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s11302-018-9637-0. Acesso em: 08 nov. 2024. , 2019
APA
Gonçalves, M. C. B., Naaldijk, Y., & Ulrich, H. (2019). Purinergic signaling in bipolar disorder. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. doi:10.1007/s11302-018-9637-0
NLM
Gonçalves MCB, Naaldijk Y, Ulrich H. Purinergic signaling in bipolar disorder [Internet]. Purinergic Signalling. 2019 ; 14 S18.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Vancouver
Gonçalves MCB, Naaldijk Y, Ulrich H. Purinergic signaling in bipolar disorder [Internet]. Purinergic Signalling. 2019 ; 14 S18.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Trabalho de evento-resumo periodico
Role of the Adenosine A2B Receptors in behavior and maturation of normal and malignant stem cells (2019)
Sherman, Lauren S; Naaldijk, Yahaira; Sandiford, O. A; Velloso, Juliana da Cruz Corrêa; Ulrich, Henning ; Rameshwar, Pranela
Source: Purinergic Signalling. Conference titles: International Basic and Translational Science on Purinergic Signaling and its Components for a Health and Better World/PURINES. Unidade: IQ
Subjects: ADENOSINA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHERMAN, Lauren S et al. Role of the Adenosine A2B Receptors in behavior and maturation of normal and malignant stem cells. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s11302-018-9637-0. Acesso em: 08 nov. 2024. , 2019
APA
Sherman, L. S., Naaldijk, Y., Sandiford, O. A., Velloso, J. da C. C., Ulrich, H., & Rameshwar, P. (2019). Role of the Adenosine A2B Receptors in behavior and maturation of normal and malignant stem cells. Purinergic Signalling. Dordrecht: Instituto de Química, Universidade de São Paulo. doi:10.1007/s11302-018-9637-0
NLM
Sherman LS, Naaldijk Y, Sandiford OA, Velloso J da CC, Ulrich H, Rameshwar P. Role of the Adenosine A2B Receptors in behavior and maturation of normal and malignant stem cells [Internet]. Purinergic Signalling. 2019 ; 14 S24.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Vancouver
Sherman LS, Naaldijk Y, Sandiford OA, Velloso J da CC, Ulrich H, Rameshwar P. Role of the Adenosine A2B Receptors in behavior and maturation of normal and malignant stem cells [Internet]. Purinergic Signalling. 2019 ; 14 S24.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1007/s11302-018-9637-0
Parte de monografia/livro
Methods of mesenchymal stem cell homing to the blood-brain barrier (2018)
Conaty, Peter; Sherman, Lauren S; Naaldijk, Yahaira; Ulrich, Henning ; Stolzing, Alexandra; Rameshwar, Pranela
Source: Methods in Molecular Biology: Somatic Stem Cells, Methods and Protocols. Unidade: IQ
Subjects: CÉLULAS-TRONCO, MEDULA ÓSSEA, BARREIRA HEMATO-ENCEFÁLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONATY, Peter et al. Methods of mesenchymal stem cell homing to the blood-brain barrier. Methods in Molecular Biology: Somatic Stem Cells, Methods and Protocols. Tradução . New York: Humana Press, 2018. . . Acesso em: 08 nov. 2024.
APA
Conaty, P., Sherman, L. S., Naaldijk, Y., Ulrich, H., Stolzing, A., & Rameshwar, P. (2018). Methods of mesenchymal stem cell homing to the blood-brain barrier. In Methods in Molecular Biology: Somatic Stem Cells, Methods and Protocols. New York: Humana Press.
NLM
Conaty P, Sherman LS, Naaldijk Y, Ulrich H, Stolzing A, Rameshwar P. Methods of mesenchymal stem cell homing to the blood-brain barrier. In: Methods in Molecular Biology: Somatic Stem Cells, Methods and Protocols. New York: Humana Press; 2018. [citado 2024 nov. 08 ]
Vancouver
Conaty P, Sherman LS, Naaldijk Y, Ulrich H, Stolzing A, Rameshwar P. Methods of mesenchymal stem cell homing to the blood-brain barrier. In: Methods in Molecular Biology: Somatic Stem Cells, Methods and Protocols. New York: Humana Press; 2018. [citado 2024 nov. 08 ]
Artigo de periodico
Purinergic receptors in neurological diseases with motor symptoms: targets for therapy (2018)
Giacomelli, Ágatha Oliveira; Naaldijk, Yahaira; Arroyo, Laura Sarda; Goncalves, Maria C. B; Velloso, Juliana Correa; Pillat, Micheli M; Souza, Hellio D. N. de; Ulrich, Henning
Source: Frontiers in Pharmacology. Unidade: IQ
Subjects: DOENÇA DE PARKINSON, ESCLEROSE AMIOTRÓFICA LATERAL, ESCLEROSE MÚLTIPLA, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIACOMELLI, Ágatha Oliveira et al. Purinergic receptors in neurological diseases with motor symptoms: targets for therapy. Frontiers in Pharmacology, v. 9, p. 1-28 art. 325, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00325. Acesso em: 08 nov. 2024.
APA
Giacomelli, Á. O., Naaldijk, Y., Arroyo, L. S., Goncalves, M. C. B., Velloso, J. C., Pillat, M. M., et al. (2018). Purinergic receptors in neurological diseases with motor symptoms: targets for therapy. Frontiers in Pharmacology, 9, 1-28 art. 325. doi:10.3389/fphar.2018.00325
NLM
Giacomelli ÁO, Naaldijk Y, Arroyo LS, Goncalves MCB, Velloso JC, Pillat MM, Souza HDN de, Ulrich H. Purinergic receptors in neurological diseases with motor symptoms: targets for therapy [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-28 art. 325.[citado 2024 nov. 08 ] Available from: https://doi.org/10.3389/fphar.2018.00325
Vancouver
Giacomelli ÁO, Naaldijk Y, Arroyo LS, Goncalves MCB, Velloso JC, Pillat MM, Souza HDN de, Ulrich H. Purinergic receptors in neurological diseases with motor symptoms: targets for therapy [Internet]. Frontiers in Pharmacology. 2018 ; 9 1-28 art. 325.[citado 2024 nov. 08 ] Available from: https://doi.org/10.3389/fphar.2018.00325
Artigo de periodico
Purinergic system in psychiatric diseases (2018)
Cheffer, Arquimedes; Castillo, Ana Regina Geciauskas Lage; Velloso, juliana da Cruz Corrêa; Gonçalves, M. C. B; Naaldijk, Yahaira; Nascimento, Isis Cristina do; Burnstock, Geoffrey; Ulrich, Henning
Source: Molecular Psychiatry. Unidade: IQ
Subjects: TRANSTORNOS MENTAIS, ADENOSINA TRIFOSFATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHEFFER, Arquimedes et al. Purinergic system in psychiatric diseases. Molecular Psychiatry, v. 23, n. 1, p. 94-106, 2018Tradução . . Disponível em: https://doi.org/10.1038/mp.2017.188. Acesso em: 08 nov. 2024.
APA
Cheffer, A., Castillo, A. R. G. L., Velloso, juliana da C. C., Gonçalves, M. C. B., Naaldijk, Y., Nascimento, I. C. do, et al. (2018). Purinergic system in psychiatric diseases. Molecular Psychiatry, 23( 1), 94-106. doi:10.1038/mp.2017.188
NLM
Cheffer A, Castillo ARGL, Velloso juliana da CC, Gonçalves MCB, Naaldijk Y, Nascimento IC do, Burnstock G, Ulrich H. Purinergic system in psychiatric diseases [Internet]. Molecular Psychiatry. 2018 ; 23( 1): 94-106.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1038/mp.2017.188
Vancouver
Cheffer A, Castillo ARGL, Velloso juliana da CC, Gonçalves MCB, Naaldijk Y, Nascimento IC do, Burnstock G, Ulrich H. Purinergic system in psychiatric diseases [Internet]. Molecular Psychiatry. 2018 ; 23( 1): 94-106.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1038/mp.2017.188
Artigo de periodico
Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches (2018)
Velloso, juliana da Cruz Corrêa; Gonçalves, Maria Carolina Bittencourt; Naaldijk, Yahaira; Giacomelli, Ágatha Oliveira; Pillat, Micheli Mainardi; Ulrich, Henning
Source: Progress in Neuropsychopharmacology & Biological Psychiatry. Unidade: IQ
Subjects: TRANSTORNO BIPOLAR, DOENÇA DE ALZHEIMER, CÉLULAS-TRONCO, LÍTIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VELLOSO, juliana da Cruz Corrêa et al. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches. Progress in Neuropsychopharmacology & Biological Psychiatry, v. 80, p. 34-53, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2017.04.033. Acesso em: 08 nov. 2024.
APA
Velloso, juliana da C. C., Gonçalves, M. C. B., Naaldijk, Y., Giacomelli, Á. O., Pillat, M. M., & Ulrich, H. (2018). Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches. Progress in Neuropsychopharmacology & Biological Psychiatry, 80, 34-53. doi:10.1016/j.pnpbp.2017.04.033
NLM
Velloso juliana da CC, Gonçalves MCB, Naaldijk Y, Giacomelli ÁO, Pillat MM, Ulrich H. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches [Internet]. Progress in Neuropsychopharmacology & Biological Psychiatry. 2018 ; 80 34-53.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.04.033
Vancouver
Velloso juliana da CC, Gonçalves MCB, Naaldijk Y, Giacomelli ÁO, Pillat MM, Ulrich H. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches [Internet]. Progress in Neuropsychopharmacology & Biological Psychiatry. 2018 ; 80 34-53.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.04.033

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Funding Agencies

Non normalized affiliation